Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of South African 501.V2 Variant on SARS-CoV-2 Spike Infectivity and Neutralization: A Structure-based Computational Assessment
Mary Hongying Cheng, James Krieger, Burak Kaynak, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 69

Showing 1-25 of 69 citing articles:

Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera
Piyada Supasa, Daming Zhou, Wanwisa Dejnirattisai, et al.
Cell (2021) Vol. 184, Iss. 8, pp. 2201-2211.e7
Open Access | Times Cited: 517
Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far?
Ivana Lazarević, Vera Pravica, Danijela Miljanovic, et al.
Viruses (2021) Vol. 13, Iss. 7, pp. 1192-1192
Open Access | Times Cited: 183
Evolutionary trajectory of SARS-CoV-2 and emerging variants
Jalen Singh, Pranav Pandit, Andrew G. McArthur, et al.
Virology Journal (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 141
Optimizing vaccine allocation for COVID-19 vaccines shows the potential role of single-dose vaccination
Laura Matrajt, Julia Eaton, Tiffany Leung, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 133
Comparative Perturbation-Based Modeling of the SARS-CoV-2 Spike Protein Binding with Host Receptor and Neutralizing Antibodies: Structurally Adaptable Allosteric Communication Hotspots Define Spike Sites Targeted by Global Circulating Mutations
Gennady M. Verkhivker, Steve Agajanian, Deniz Yazar Oztas, et al.
Biochemistry (2021) Vol. 60, Iss. 19, pp. 1459-1484
Open Access | Times Cited: 79
FnCas9-based CRISPR diagnostic for rapid and accurate detection of major SARS-CoV-2 variants on a paper strip
Manoj Kumar, Sneha Gulati, Asgar Hussain Ansari, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 73
E484K mutation in SARS-CoV-2 RBD enhances binding affinity with hACE2 but reduces interactions with neutralizing antibodies and nanobodies: Binding free energy calculation studies
Wei Bu Wang, Yu Liang, Yu Jin, et al.
Journal of Molecular Graphics and Modelling (2021) Vol. 109, pp. 108035-108035
Open Access | Times Cited: 70
Molecular Aspects Concerning the Use of the SARS-CoV-2 Receptor Binding Domain as a Target for Preventive Vaccines
Yury Valdés-Balbín, Darielys Santana-Mederos, Françoise Paquet, et al.
ACS Central Science (2021) Vol. 7, Iss. 5, pp. 757-767
Open Access | Times Cited: 62
ACE2 is the critical in vivo receptor for SARS-CoV-2 in a novel COVID-19 mouse model with TNF- and IFNγ-driven immunopathology
Riem Gawish, Philipp Starkl, Lisabeth Pimenov, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 55
Impact of new variants on SARS-CoV-2 infectivity and neutralization: A molecular assessment of the alterations in the spike-host protein interactions
Mary Hongying Cheng, James Krieger, Anupam Banerjee, et al.
iScience (2022) Vol. 25, Iss. 3, pp. 103939-103939
Open Access | Times Cited: 47
Dynamic Profiling of Binding and Allosteric Propensities of the SARS-CoV-2 Spike Protein with Different Classes of Antibodies: Mutational and Perturbation-Based Scanning Reveals the Allosteric Duality of Functionally Adaptable Hotspots
Gennady M. Verkhivker, Steve Agajanian, Deniz Yaşar Öztaş, et al.
Journal of Chemical Theory and Computation (2021) Vol. 17, Iss. 7, pp. 4578-4598
Closed Access | Times Cited: 54
Rapid Increase of SARS-CoV-2 Variant B.1.1.7 Detected in Sewage Samples from England between October 2020 and January 2021
Thomas Wilton, Erika Bujáki, Dimitra Klapsa, et al.
mSystems (2021) Vol. 6, Iss. 3
Open Access | Times Cited: 53
Emergence and phenotypic characterization of C.1.2, a globally detected lineage that rapidly accumulated mutations of concern
Cathrine Scheepers, Josie Everatt, Daniel G. Amoako, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 51
SARS-CoV-2 Entry Related Viral and Host Genetic Variations: Implications on COVID-19 Severity, Immune Escape, and Infectivity
Szu‐Wei Huang, Sheng‐Fan Wang
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 6, pp. 3060-3060
Open Access | Times Cited: 46
Versatile role of ACE2-based biosensors for detection of SARS-CoV-2 variants and neutralizing antibodies
Jong-Hwan Lee, Yungmin Lee, Sung Kyun Lee, et al.
Biosensors and Bioelectronics (2022) Vol. 203, pp. 114034-114034
Open Access | Times Cited: 38
Effects of Spike Mutations in SARS-CoV-2 Variants of Concern on Human or Animal ACE2-Mediated Virus Entry and Neutralization
Yunjeong Kim, Natasha N. Gaudreault, David A. Meekins, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 3
Open Access | Times Cited: 30
The Variation of SARS-CoV-2 and Advanced Research on Current Vaccines
Yao Jiang, Qian Wu, Peipei Song, et al.
Frontiers in Medicine (2022) Vol. 8
Open Access | Times Cited: 29
SARS-CoV-2 Variants and Their Relevant Mutational Profiles: Update Summer 2021
Mohammad Alkhatib, Valentina Svicher, Romina Salpini, et al.
Microbiology Spectrum (2021) Vol. 9, Iss. 3
Open Access | Times Cited: 40
Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assay
Ester López, Ebene R. Haycroft, Amy Adair, et al.
JCI Insight (2021) Vol. 6, Iss. 16
Open Access | Times Cited: 37
Bioinformatics analysis of the differences in the binding profile of the wild-type and mutants of the SARS-CoV-2 spike protein variants with the ACE2 receptor
Muhammad Suleman, Qudsia Yousafi, Javaid Ali, et al.
Computers in Biology and Medicine (2021) Vol. 138, pp. 104936-104936
Open Access | Times Cited: 35
Cross-validation of SARS-CoV-2 responses in kidney organoids and clinical populations
Louisa Helms, Silvia Marchianò, Ian B. Stanaway, et al.
JCI Insight (2021) Vol. 6, Iss. 24
Open Access | Times Cited: 34
Impact of the N501Y substitution of SARS-CoV-2 Spike on neutralizing monoclonal antibodies targeting diverse epitopes
Lin Cheng, Shuo Song, Bing Zhou, et al.
Virology Journal (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 33
In Silico Analysis of Bacteriocins from Lactic Acid Bacteria Against SARS-CoV-2
İsmail Erol, Seyfullah Kotil, Özkan Fidan, et al.
Probiotics and Antimicrobial Proteins (2021) Vol. 15, Iss. 1, pp. 17-29
Open Access | Times Cited: 32
Shooting at a Moving Target—Effectiveness and Emerging Challenges for SARS-CoV-2 Vaccine Development
Franziska Günl, Angeles Mecate‐Zambrano, Selina Rehländer, et al.
Vaccines (2021) Vol. 9, Iss. 10, pp. 1052-1052
Open Access | Times Cited: 29
Single domain shark VNAR antibodies neutralize SARS‐CoV‐2 infection in vitro
Aziz Gauhar, Cyril V. Privezentzev, Mykhaylo Demydchuk, et al.
The FASEB Journal (2021) Vol. 35, Iss. 11
Open Access | Times Cited: 29
Page 1 - Next Page

Scroll to top